A cross sectional study on the motivators for Asian women to attend opportunistic mammography screening in a private hospital in Malaysia: the MyMammo study by unknown
Hassan et al. BMC Public Health  (2015) 15:548 
DOI 10.1186/s12889-015-1892-1RESEARCH ARTICLE Open AccessA cross sectional study on the motivators for Asian
women to attend opportunistic mammography
screening in a private hospital in Malaysia: the
MyMammo study
Norhashimah Hassan1,2, Weang Kee Ho3, Shivaani Mariapun1,2 and Soo Hwang Teo1,2*Abstract
Background: To date, because of limited budgets and lower incidence of breast cancer, the majority of Asian
countries do not have population-based screening programmes, but instead offer opportunistic screening. However,
there have been few studies which have assessed the motivators for women attending such programmes and the
appropriateness of the programmes in terms of targeting women at risk.
Methods: We conducted a prospective cross-sectional study of 1,619 women aged 40 to 74 years attending a
subsidized opportunistic screening mammogram from October 2011 to October 2013 at a private hospital in
Malaysia. Breast cancer risk was estimated using the Gail Model and two-step cluster analysis was used to examine the
motivators of attending screening.
Results: Although Malaysia comprises 54.5 % Malay, 24.5 % Chinese and 7.3 % Indian, the majority of women in the
MyMammo Study were Chinese (70.1 %) and 99.2 % had a <2 % ten-year risk of breast cancer. The most commonly
cited barriers were the perception of not being at risk and fear of painful mammography. We found that highly
educated women, cited doctors, family and friends as their main motivators. Of those with only secondary
school education, their main motivators were doctors.
Conclusions: Taken together, our results suggest the women attending opportunistic mammography screening
in Asia are at low risk of breast cancer and this poses challenges to cost-effective and equitable strategies for
cancer control. We propose that to improve uptake of screening mammography, awareness programmes should
target both doctors and members of the public.
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Breast cancer is the most common cancer in women
and accounts for ~12.7 % of all cancer deaths in Asian
women [1]. Although breast cancer incidence is lower in
Asia compared to that in Western countries, it is now
rising rapidly in Asian countries because of longer life
expectancy and dramatic changes in parity and lifestyle* Correspondence: Soohwang.teo@carif.com.my
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creativecommons.org/publicdomain/zero/1.0/[1–4]. The increasing burden of breast cancer in Asian
countries is exacerbated by late presentation and limited
access to therapies, resulting in poorer outcomes [5–7].
In high-income Asian countries with higher breast
cancer incidence, such as Singapore, Korea and Japan,
organized national mammographic screening is available,
but uptake varies from 20 to 57 % [8–12]. In the other
Asian countries, only opportunistic screening is available
[13] and uptake is generally low, ranging from <1 % in
Thailand [14], to ~7 % among rural Malaysian women
[15–17]. A number of reasons for poor uptake have been
described in Singapore, Thailand, Malaysia and Iran, andrticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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screening facilities and fear of cancer [14, 18–20].
Faced with limited budgets and an increasing inci-
dence of breast cancer, the governments of Asian coun-
tries are facing difficult decisions on how to offer
screening equitably and cost-effectively, and in particu-
lar, how to target limited resources to women at higher
risk of developing breast cancer. However, there is pau-
city of data on the risk profile of Asian women attending
opportunistic screening and limited data on how to mo-
tivate women to come forward for screening. In this
study, we sought to describe the risk profile of women
attending opportunistic screening at a private hospital in
Malaysia, to examine the barriers and motivators of
women attending screening, and to explore whether
there are subgroups of healthy women with similar self-
reported motivators for attending screening in Malaysia.
Findings from these analyses may inform the utility of
opportunistic mammography screening and further, the
functional clustering may provide insight into how
screening messages should be framed for more effective
promotion of screening mammography in the future.
Methods
Study description
The Malaysian Mammography Study [MyMammo] is
a subsidized opportunistic mammogram screening
programme in a private tertiary hospital located in a
suburban area in Malaysia. Screening was offered to
women who did not have a personal history of breast can-
cer and who have not had a mammogram for at least one
year prior to participating in the programme. Participants
were recruited using flyers and posters at the hospital, and
articles in the mainstream English, Chinese and Malay
media. From October 2011 to October 2013, 1,619 women
were enrolled into the study. Participants had a digital
mammogram, donated a blood sample for research and
completed a questionnaire of information in relation
to demographic characteristics, anthropometric factors,
menstrual and reproductive history, family history of can-
cer and, motivators and barriers for participating in the
MyMammo study. Women were excluded if they were
younger than 40 years old (n = 6), older than 74 years old
(n = 4), previously diagnosed with other cancer (n = 23) or
symptomatic (n = 133), leaving 1,453 in the final analysis.
All women provided informed consent and this study was
approved by the Sime Darby Medical Centre Independent
Ethics Committee.
Estimation of breast cancer risk
The ten-year risk of breast cancer in all women were
calculated at age of participation in MyMammo study
using the publicly available Gail Model by including the
following variables: age at menarche (<12 years, 12-13years, ≥14 years), age at first live birth (<20 years, 20-24
years, 25-29 years, ≥30 years), history of previous breast
surgery and the number of first degree relatives affected
with breast cancer. Subjects were categorized as parous
if they have had at least one full term pregnancy (live or
still births) and the family history of breast cancer in a
first degree relative included affected mothers and sis-
ters. For calculations of population risk to breast cancer,
the population risk of the Malaysian Chinese was based
on that of the Chinese Asian-Americans while the popu-
lation risk of Malaysian Malay and Indian women was
based on that of other Asian-Americans [21].
Statistical analysis
SPSS software [Version 21] was used for all data ana-
lysis. The association between mammography history
and baseline characteristics was investigated using Stu-
dent’s t test and chi-square test for continuous and
categorical variables respectively. A two-step cluster ana-
lysis was used to identify sub-groups of women with
similar self-reported motivators for participating in the
MyMammo Study. Women with previous breast biopsy
(n = 136) were excluded, leaving a total of 1,317 women
for analysis. Initial analysis included all variables and
thereafter, variables without significant association with
mammography history were removed sequentially (starting
with the least significant variables). Models with acceptable
cluster quality, smallest Schwarz’s Bayesian Criterion and
significant differences between socio-demographic variables
and motivators were selected. Differences between clusters
were determined by Kruskal-wallis test for continuous
variables and chi-square test for categorical variables.
Results
Study cohort
The MyMammo study is an opportunistic mammog-
raphy screening programme established at a private hos-
pital in the suburban area of Subang Jaya in Malaysia.
The mean age was 50 years old, the majority of partici-
pants were Chinese [70.1 %], >90 % had secondary or
tertiary education and 19 % were considered high in-
come. The mean age of menarche was 13 years old and
84 % of women were parous, with a mean age of first
live birth of 28 years old. Whilst 30 % of women had
ever used oral contraceptives, less than 10 % had used
hormone replacement therapy. Only 10 % of women
report a family history of breast cancer and 9 % had previ-
ously had a breast biopsy. Twenty one percent of patients
had previously had gynaecological surgery. Overall, the
mean ten-year risk for women aged 40-79 was 0.77 %,
ranging from 0.4 % to 14.4 %. The majority of women
(n = 1453, 99.2 %) were estimated to have a <2 % risk of
breast cancer, with only 0.8 % (n = 19) at 2 % risk
(Fig. 1).
Fig. 1 Distribution for ten-year risk invasive breast cancer in participants of the MyMammo study. Low risk is defined by having 10-year risk of less
than 2 % while high risk is defined by 2 % or greater risk of developing breast cancer in the next 10 years. The majority of women (n=1415, 97.3 %) were
at low risk of breast cancer and 38 out of 1453 of women (2.7 %) is predicted to be at risk of developing invasive breast cancer in the next 10 years
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0.001), tend to have higher socio-economic status (in-
come p = 0.01, educational level p = 0.006), more likely
to be menopausal (p < 0.001), have first live birth at an
older age (p = 0.001), and more likely to have had hor-
mone replacement therapy (p < 0.001) compared to
women without previous mammogram. They also have
higher proportion of positive family history of breast
cancer (p < 0.001) and diabetic (p = 0.05). The remaining
variables, namely ethnicity, age at menarche, smoking
status and previous breast or gynaecological surgery,
did not differ significantly between the two groups
(Table 1).
For 709 women (48.8 %) that cited the MyMammo
Study as their first breast screening mammogram, 30 %
(209) cited perception that they are not at risk, 20 %
(139) cited fear of painful mammography, and 10 % (68)
cited cost, as barriers of attending opportunistic screening.
Cluster analysis
Whilst the association analyses revealed the differences
between women who have previously attended mammo-
gram compared with those who had not, it did not re-
veal whether there were subgroups of healthy women
with similar self-reported motivators for attending op-
portunistic screening in Malaysia. To do this, we con-
ducted a cluster analysis to determine the characteristics
of women presenting for opportunistic screening, start-
ing first with a model containing all variables in Table 1,
mammography history, age at first mammogram and
motivators for attending screening, and sequentially
excluding variables with the least association with
mammography history (Table 2). We observed that the
full model and Model two generated more than threeclusters with poor separation. Models 1, 3, 4 and 6, and
Models 5, 7 and 8 generated two and three clusters, re-
spectively, with fair cluster quality and similar profiles.
However, only the three-cluster models show a signifi-
cant difference between motivators. Although there is
a slight increase in BIC value after dropping parity and
menopausal status from the analysis (comparing Model
5 with Model 8), the most parsimonious model was
Model 8, as it contained the least variables and all variables
in the model remained significantly different between the
three clusters (Table 3).
The first and largest cluster (N = 451) comprised older
women (mean age 52 years), all of whom have had a
mammogram previously (mean age of first mammogram
44 years). Notably, women in cluster 1 had the most sig-
nificant family history of breast cancer (13.1 %) and the
motivators for participating in opportunistic screening
were varied (family and friends, doctors, themselves and
public campaign).
Cluster 2 is the smallest group (N = 262) and consists
of younger participants (mean age 45 years), the majority
of whom have never had a mammogram (98.5 %). They
are the most highly educated (75 % have attended col-
lege or university) and have the highest monthly income
(38 % earned above RM10,000 per month). Women of
this cluster had the smallest proportion of overweight
(35.9 %) or diabetic women (2.7 %) and the lowest use of
hormone replacement therapy (2.7 %). These women
were motivated to attend opportunistic screening by
their doctors, family or friends.
Cluster 3 (N = 276) consists of older women (mean age
51 years), the majority of whom have never had a mammo-
gram previously (93.8 %). Women in this cluster had the
lowest socio-economic status: 98.9 % were educated at
Table 1 Malaysian Mammographic Study cohort description by mammography history
Variable All women Previous mammogram First mammogram P value
N = 1453 N = 744 N = 709
N % N % N %
Demographics
Age1a[mean, sd] 50.0 7.0 53.0 7.0 48.0 7.0 <0.001
Ethnicity2a
Chinese 1018 70.1 530 71.2 488 68.8 0.194
Indian 223 15.4 117 15.7 106
Malay 160 69 9.3 91 12.8
Others 52 3.5 28 3.8 24 3.4
Education Level2
Primary 90 6.2 34 4.6 56 8.1 0.006
Secondary 728 50.1 366 49.9 362 52.3
Tertiary 608 41.8 334 45.5 274 39.6
Missing 27 10 17
Monthly Income (RM)2
Below 5 k 689 47.4 325 44.1 364 52.1 0.010
5 k to 10 k 470 32.4 260 35.3 210
Above 10 k 277 19.1 152 20.6 125 17.9
Missing 20 10 10
Hormonal
Endogenous
Age at menarche1a[mean, sd] 13.0 1.0 13.0 1.0 13.0 1.0 0.626
Missing 10 5 5
Menopausal status2
Pre/perimenopausal 783 53.9 299 40.2 484 68.6 <0.001
Post-menopausal 667 45.9 445 59.8 222 31.4
Missing 3 0 3
Parity2
Nulliparous 229 15.8 104 125 17.6 0.057
Parous 1224 84.2 640 584 82.4
Age at first live births1a[mean, sd] 28.0 5.0 28.0 5.0 27.0 5.0 0.001
Missing 230 105 125
Exogenous
Oral contraceptive usage status2
Never 1004 69.1 508 68.5 496 70.4 0.435
Ever used 443 30.5 234 31.5 209 29.6
Missing 6 2 4
Hormone replacement therapy
(HRT) status2
Never 1306 89.9 627 84.6 679 <0.001
Ever used 142 9.8 114 15.4 28
Missing 5 3 2
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Table 2 Summary for two-step cluster analysis
Model Exclusiona Number of Clusters Schwarz's Bayesian Criterion (BIC) Cluster quality
Full model None 4 18827.990 Poor
Model 1 Exclude smoking status 2 18959.512 Fair
Model 2 Exclude age at menarche 5 16456.869 Poor
Model 3 Exclude oral contraceptive status 2 16212.759 Fair
Model 4 Exclude Gynaecology surgery status 2 15089.163 Fair
Model 5 Exclude ethnicity 3 12973.058 Fair
Model 6 Exclude parity status 2 13416.631 Fair
Model 7 Exclude menopausal status include parity 3 13372.869 Fair
Model 8 Exclude menopausal status 3 13453.375 Fair
aFull model consists of all variables in Table 1, mammography history, age at first screening and motivators for attending screening. Model 1 – Model 8:
sequentially excluding variables with least association with mammography history
Table 1 Malaysian Mammographic Study cohort description by mammography history (Continued)
Medical history
Family history of breast cancer2a
No 1301 89.5 646 86.8 655 92.4 <0.001
Yes 152 10.5 98 13.2 54 7.6
Previous breast biopsy status2a
No 1305 89.8 676 91.5 629 89.6 0.224
Yes 136 9.4 63 8.5 73 10.4
Missing 12 5 7
Gynaecological surgery2
No 1143 78.7 578 79.7 565 79.7 0.352
Yes 310 21.3 166 22.3 144 20.3
Sterilisation 103 7.1 52 51 7.2
Oopherectomy 33 2.3 21 2.8 12 1.7
Hysterectomy 82 5.6 40 5.4 42 5.9
Total Hysterectomy/TAHBSO 69 4.8 37 32 4.5
Salpingectomy/salpingostomy 23 1.6 16 2.1 7
Body Mass Index (BMI)2
Underweight 48 3.3 16 32 4.5 0.030
Normal weight 812 55.9 425 57.1 387
Overweight 576 39.6 292 284 40.0
Missing 17 11 6
Diabetes status2
No 1335 91.9 673 91.1 662 93.8 0.050
Yes 110 7.6 66 8.9 44 6.2
Missing 8 5 3
Smoking status2
Never 1312 90.3 671 90.2 641 90.4 0.887
Ever smoked 141 9.7 73 9.8 68 9.6
aIndicates variables in the Gail Model
1Indicates continuous variable
2Indicates categorical variable
T-test was used for continuous variables and chi-square test for categorical variables
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Table 3 Groups of asymptomatic healthy women attending Malaysian Mammographic study using the cluster analysis (N = 989)
Cluster 1 Cluster 2 Cluster 3 P-value
N = 451 N = 262 N = 276
Mean sd Mean sd Mean sd
Age (years)a 52 6.0 45 5.0 51 8.0 <0.001
Age at first mammogram (years)a 44 6.0 45 5.0 50 7.0 <0.001
Age at first live birth (years)a 28 4.0 29 4.0 25 5.0 <0.001
N % N % N %
Previous mammogram statusb
Never had a mammogram before 0 0.0 258 98.5 259 93.8 <0.001
Have had a mammogram before 451 100.0 4 1.5 17 6.2
Education levelb
Primary 9 2.0 0 0.0 54 19.6 <0.001
Secondary 222 49.2 66 25.2 219 79.3
Tertiary 220 48.8 196 74.8 3 1.1
Monthly income (RM)b
Below 5 k 180 39.9 36 13.7 236 85.5 <0.001
5 k to 10 k 164 36.4 127 48.5 37 13.4
Above 10 k 107 23.7 99 37.8 3 1.1
Family history of breast cancerb
None 392 86.9 237 90.5 261 94.6 0.009
1 affected individuals 54 12.0 25 9.5 14 5.1
2 affected individuals 5 1.1 0 0.0 1 0.4
HRT Usageb
Never 384 85.1 255 97.3 259 93.8 <0.001
Ever used 67 14.9 7 2.7 17 6.2
BMIb
Underweight 8 1.8 6 2.3 6 2.2 0.001
Normal weight 264 58.5 162 61.8 126 45.7
Overweight 179 39.7 94 35.9 144 52.2
Diabetes statusb
Unaffected 420 93.1 255 97.3 235 85.1 <0.001
Affected 31 6.9 7 2.7 41 14.9
Motivators for first mammogramb
Family & Friends 147 32.6 52 19.8 25 9.1 <0.001
Doctor 92 20.4 75 28.6 119 43.1
Myself 67 14.9 16 6.1 23 8.3
Public campaign 60 13.3 34 13.0 14 5.1
More than 1 motivators 37 8.2 23 8.8 17 6.2
No motivators 48 10.6 62 23.7 78 28.3
aIndicates continuous variable
bIndicates categorical variable
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income of lower than RM5,000. Women from this cluster
had their first live birth at the youngest age (25 years), had
the least significant family history of breast cancer, and thelargest proportion of diabetic (14.9 %) and overweight
women (52.2 %). Significantly, amongst these older women
from a lower socio-economic group, the majority were mo-
tivated by their doctors to attend opportunistic screening.
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further examination indicated that cluster 1 had the
highest proportion among Indian women (70 out of 223,
31 %) and cluster 2 the highest among Malay women
(76 out of 160, 44 %).
Discussion
The incidence of breast cancer is rising in most parts of
Asia and Asian governments, particularly those from
low and middle-income countries, face significant chal-
lenges in providing cost-effective and equitable screening
for breast cancer. To date, the majority of low and
middle-income Asian countries only offer opportunistic
screening and the aspiration is that through health edu-
cation and community health programmes, awareness
and uptake of screening can help to ensure earlier pres-
entation. In this study, we show that the majority of
women attending opportunistic screening have an esti-
mated <2 % risk of breast cancer in the next ten years, a
threshold which is often considered where the benefits
of screening outweigh the potential harms of over-
diagnosis. This suggests that opportunistic screening in
a private hospital in Malaysia does not target the women
at high risk of breast cancer.
Previous studies using logistic regression have demon-
strated a number of variables are associated with partici-
pation in mammography screening, but these studies
provide limited information on how to target different
groups of women [17, 18, 22]. In our study, we applied a
different analytical method and suggest that functional
clustering has provided insight into how screening mes-
sages should be framed for more effective promotion of
mammography screening in the future. First, women
with a higher risk of breast cancer on the basis of family
history of breast cancer were more likely to attend
screening at a younger age and they were motivated to
participate in screening by various avenues. This sug-
gests that health education focusing on the familial risk
of breast cancer could be a strong motivator for Asian
women to participate in screening but this approach has
not hitherto been explored. Second, highly educated
women could be motivated through a number of ave-
nues including by their doctors, by family and friends or
by public campaigns. Third, women in lower socio-
economic classes were more likely to be motivated by
their doctors to participate in screening. Taken together,
this suggests that whilst highly educated women were
accessible through public campaigns, women in lower
socio-economic classes may not respond similarly to
such campaigns. This is consistent with a systematic re-
view of interventions to increase uptake of screening mam-
mography among Asian women which suggests that media
campaigns alone may be ineffective in increasing screening
uptake [9]. In addition, our data suggests that doctorsremain a significant avenue for educating women in lower
socio-economic groups about screening and health educa-
tion should specifically encourage primary care physicians
to educate their clients about the potential benefits of
screening. This is consistent with studies in Indian,
Pakistani and Bangladeshi women in the UK where
cultural awareness training for healthcare workers was
found to increase mammography uptake [23].
The strength of the MyMammo study is the relatively
large sample size and availability of data on breast can-
cer risk factors, which in turns enable the determination
of the estimated risk of breast cancer. To date, reports
on barriers and motivators among developing Asian
countries have been limited to small cohorts, with lim-
ited information about breast cancer risk factors. How-
ever, the MyMammo study has a number of limitations.
First, the study is conducted in a private hospital and
study participants were asked to contribute a blood sam-
ple for research to determine genetic determinants of
mammographic density. It is unknown whether these
would have affected participation levels and the profiles
of participating women. Second, as this is an opportunistic
screening program, findings from this study cannot be
extrapolated to the general population as it only represents
a subset of women that came forward for screening.
Conclusions
The MyMammo Study has shown that the avenues for
women to become aware of and be motivated to partici-
pate in opportunistic screening is different in high-income
and low socio-economic women. Findings from this study
may have implications on the approach of future health
education and community awareness programmes in
Malaysia and other Asian countries.
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